Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial.
Higginson IJ, Brown ST, Oluyase AO, May P, Maddocks M, Costantini M, Bajwah S, Normand C, Bausewein C, Simon ST, Ryan K, Currow DC, Johnson MJ, Hart SP, Mather H, Krajnik M, Tanzi S, Ghirotto L, Bolton CE, Janowiak P, Turola E, Jolley CJ, Murden G, Wilcock A, Farsides B, Brown JM; BETTER-B consortium.
Higginson IJ, et al. Among authors: farsides b.
Lancet Respir Med. 2024 Oct;12(10):763-774. doi: 10.1016/S2213-2600(24)00187-5. Epub 2024 Sep 9.
Lancet Respir Med. 2024.
PMID: 39265600
Free article.
Clinical Trial.